Companies / Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.
Insider flow · last 90 daysNet sells $175.04M
Financials · FY2025
Ownership
83.2M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 2.61% | 2,170,117 |
| 10%+ / strategic | 10.74% | 8,928,574 |
| Institutions | 99.17% | 82,462,957 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 25
View all →| Insider | % of shares | Shares |
|---|---|---|
Booth BruceDirector | 0.81% | 675,341 |
Mainolfi NelloCEOChief Executive Officer · Director | 0.80% | 666,195 |
Bvf Partners L P/ILDirector | 0.38% | 318,910 |
Jacobs Bruce N.Chief Financial Officer | 0.28% | 232,588 |
Gollob JaredChief Medical Officer | 0.14% | 117,134 |
Goodman NoahChief Business Officer | 0.07% | 59,306 |
Adams BrianChief Legal Officer | 0.07% | 56,625 |
Chadwick Jeremy GChief Operating Officer | 0.05% | 44,018 |
Esposito PamelaDirector | 0.00% | 0 |
667, L.P.Director · 10% owner | — | — |
Institutional holders 264
View all →| Holder | Value | % of shares |
|---|---|---|
| $721.06M | 10.41% | |
| $694.73M | 10.74% | |
| $635.07M | 6.66% | |
| $581.61M | 8.99% | |
| $487.69M | 7.54% | |
| $458.32M | 6.62% | |
| $362.58M | 5.60% | |
| $343.37M | 5.31% | |
| $313.88M | 3.29% | |
| $255.75M | 3.95% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $89.24M | -838K -29.94% | 1,960,881 2.36% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $66.84M | -628K -28.27% | 1,592,261 1.91% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $12.07M | -113K -32.06% | 240,123 0.29% of shares | high |
| Mar 2, 2026 | Booth Bruce Director | Sell | Common Stock | $6.47M | -72K -1.81% | 3,902,667 4.69% of shares | medium |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $5.52M | -52K -39.69% | 78,787 0.09% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $4.09M | -53K -40.85% | 76,721 0.09% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $2.50M | +84K +124.02% | 152,452 0.18% of shares | low |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.98M | -25K -28.78% | 61,202 0.07% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| KYMR | — | 501575104 |